Target intelligence / Profile preview

RNA, variant U1 small nuclear 30 (RNVU1-30)

Target
RNVU1-30
Molecular classification
Small nuclear RNA (snRNA)
01

Overview

RNA, variant U1 small nuclear 30 (RNVU1-30) is a member of the small nuclear RNA (snRNA) class related to the canonical U1 snRNA, which is a core component of the spliceosome, the complex responsible for pre-mRNA splicing in eukaryotes[1][2][5]. The canonical U1 snRNA binds to the 5' splice site of pre-messenger RNA, playing a crucial role in defining exon-intron boundaries and enabling correct mRNA maturation[2]. RNVU1-30 is a variant and is predicted to be involved in pre-mRNA 5'-splice site recognition by forming part of the U1 snRNP complex, although biochemical studies indicate that U1 variants generally assemble less efficiently into snRNPs and bind core proteins with lower affinity than canonical U1 snRNA[2]. No evidence supports direct involvement of RNVU1-30 as a therapeutic target, its association with specific diseases, interacting drugs, or use as a biomarker[1][2][5].

Other names
U1 snRNA variant 30U1 small nuclear RNA variant 30
02

Biological functions

Spliceosomal RNAParticipates in mRNA 5'-splice site recognitionForms part of U1 small nuclear ribonucleoprotein (snRNP) complex

Beyond the preview

Go deeper on RNA, variant U1 small nuclear 30 (RNVU1-30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, variant U1 small nuclear 30 (RNVU1-30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call